PRIMARY MYELOFIBROSIS (PMF)
Clinical trials for PRIMARY MYELOFIBROSIS (PMF) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MYELOFIBROSIS (PMF) trials appear
Sign up with your email to follow new studies for PRIMARY MYELOFIBROSIS (PMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new pill tame myelofibrosis?
Disease control CompletedThis trial is testing an experimental oral drug called PXS-5505 (amsulostat) in people with myelofibrosis, a type of bone marrow cancer. The study focuses on patients who are not eligible for a stem cell transplant. The main goal is to see if the drug is safe and tolerable, and t…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Phase: PHASE1, PHASE2 • Sponsor: Syntara • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Scientists uncover clues to inflammation in rare bone marrow disease
Knowledge-focused CompletedThis study looked at 70 people—some with primary myelofibrosis and some healthy—to understand how certain immune cells called MDSCs fuel inflammation in this rare bone marrow disease. Researchers also checked how these cells change with treatment and whether they help form new bl…
Matched conditions: PRIMARY MYELOFIBROSIS (PMF)
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC